160 related articles for article (PubMed ID: 33140294)
1. Anxiety and depression in glioma patients: prevalence, risk factors, and their correlation with survival.
Hao A; Huang J; Xu X
Ir J Med Sci; 2021 Aug; 190(3):1155-1164. PubMed ID: 33140294
[TBL] [Abstract][Full Text] [Related]
2. Anxiety and depression in rheumatoid arthritis patients: prevalence, risk factors and consistency between the Hospital Anxiety and Depression Scale and Zung's Self-rating Anxiety Scale/Depression Scale.
Cheng L; Gao W; Xu Y; Yu Z; Wang W; Zhou J; Zang Y
Rheumatol Adv Pract; 2023; 7(3):rkad100. PubMed ID: 38033365
[TBL] [Abstract][Full Text] [Related]
3. Two-scale assessment of anxiety and depression in postoperative non-small cell lung cancer patients: their prevalence, risk factors, and prognostic potency.
Deng L; Chen B
Ir J Med Sci; 2023 Dec; 192(6):2613-2619. PubMed ID: 36826710
[TBL] [Abstract][Full Text] [Related]
4. Hospital anxiety and depression scale exhibits good consistency but shorter assessment time than Zung self-rating anxiety/depression scale for evaluating anxiety/depression in non-small cell lung cancer.
Guo C; Huang X
Medicine (Baltimore); 2021 Feb; 100(8):e24428. PubMed ID: 33663054
[TBL] [Abstract][Full Text] [Related]
5. Postoperative anxiety and depression in surgical gastric cancer patients: their longitudinal change, risk factors, and correlation with survival.
Liu P; Wang Z
Medicine (Baltimore); 2022 Mar; 101(11):. PubMed ID: 35356898
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Hospital Anxiety and Depression Scale (HADS) and Zung Self-Rating Anxiety/Depression Scale (SAS/SDS) in Evaluating Anxiety and Depression in Patients with Psoriatic Arthritis.
Yue T; Li Q; Wang R; Liu Z; Guo M; Bai F; Zhang Z; Wang W; Cheng Y; Wang H
Dermatology; 2020; 236(2):170-178. PubMed ID: 31434087
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Assessment of Prevalence and Risk Factors of Anxiety and Depression among Prostate Cancer Survivors Post-Resection.
Yu R; Li H
Psychiatr Q; 2021 Sep; 92(3):995-1009. PubMed ID: 33409928
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, risk factors and prognostic value of anxiety and depression in recurrent glioma patients.
Liu X; Zhan G
Psychol Health Med; 2023; 28(9):2474-2485. PubMed ID: 37271963
[TBL] [Abstract][Full Text] [Related]
9. Anxiety and depression during 3-year follow-up period in postoperative gastrointestinal cancer patients: prevalence, vertical change, risk factors, and prognostic value.
Li J; Ma C
Ir J Med Sci; 2023 Dec; 192(6):2621-2629. PubMed ID: 36862310
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and correlation of anxiety and depression on the prognosis of postoperative non-small-cell lung cancer patients in North China.
Huang X; Zhang TZ; Li GH; Liu L; Xu GQ
Medicine (Baltimore); 2020 Mar; 99(11):e19087. PubMed ID: 32176035
[TBL] [Abstract][Full Text] [Related]
11. The longitudinal changes of anxiety and depression, their related risk factors and prognostic value in colorectal cancer survivors: a 36-month follow-up study.
Zhou L; Sun H
Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101511. PubMed ID: 33713979
[TBL] [Abstract][Full Text] [Related]
12. Reminiscence therapy-based care program for reducing anxiety and depression in glioma survivors: A randomized controlled trial.
Zhao X
Medicine (Baltimore); 2021 Feb; 100(5):e23056. PubMed ID: 33592815
[TBL] [Abstract][Full Text] [Related]
13. Intensive patient's care program reduces anxiety and depression as well as improves overall survival in
Bao H; Chen Y; Li M; Pan L; Zheng X
Transl Cancer Res; 2019 Feb; 8(1):212-227. PubMed ID: 35116750
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Risk Factors for Anxiety and Depression in Patients With COVID-19 in Wuhan, China.
Li T; Sun S; Liu B; Wang J; Zhang Y; Gong C; Duan J
Psychosom Med; 2021 May; 83(4):368-372. PubMed ID: 33951724
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, risk factors, and prognostic value of anxiety and depression in acute myeloid leukemia.
Zhong T; Xu D; Li W
Acta Haematol; 2024 Feb; ():. PubMed ID: 38342094
[TBL] [Abstract][Full Text] [Related]
16. Risk factors, prognostic potency, and longitudinal variation of anxiety and depression in postoperative glioma patients.
Wu X; Wang D; Wang D
Front Surg; 2022; 9():1069709. PubMed ID: 36726957
[TBL] [Abstract][Full Text] [Related]
17. The effect of an intensive patients' education program on anxiety, depression and patient global assessment in diabetic foot ulcer patients with Wagner grade 1/2: A randomized, controlled study.
Chen H; Cai C; Xie J
Medicine (Baltimore); 2020 Feb; 99(6):e18480. PubMed ID: 32028385
[TBL] [Abstract][Full Text] [Related]
18. Enzalutamide alleviates anxiety and depression as well as improves quality of life compared to bicalutamide in metastatic castration-resistant prostate cancer patients: a cohort study.
Guo F; Li GH
Transl Cancer Res; 2019 Sep; 8(5):1965-1974. PubMed ID: 35116945
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors for depression and anxiety among outpatient migraineurs in mainland China.
Yong N; Hu H; Fan X; Li X; Ran L; Qu Y; Wang Y; Tan G; Chen L; Zhou J
J Headache Pain; 2012 Jun; 13(4):303-10. PubMed ID: 22466285
[TBL] [Abstract][Full Text] [Related]
20. Post-surgery anxiety and depression in prostate cancer patients: prevalence, longitudinal progression, and their correlations with survival profiles during a 3-year follow-up.
Hu S; Li L; Wu X; Liu Z; Fu A
Ir J Med Sci; 2021 Nov; 190(4):1363-1372. PubMed ID: 33411223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
